HOME >> BIOLOGY >> NEWS
Progress report on Homogeneous Assay project

International medical diagnostics company Panbio Limited today announced that it has achieved some encouraging results in the development of its Homogeneous Assay Technology.

The company's Advanced Technologies Division has developed a pair of pre-prototype assays for HSV-1 and HSV-2 antibody detection.* The key achievements of this development are:

  • The results obtained were based on real samples whereas, earlier in the project, results were based on a model assay; and
  • The results obtained were consistent with those obtained when using the current ELISA technology.

The company was also pleased that, at this early stage in the project, the results were obtained in less than 50% of the time taken on current ELISA technology.

The development of the assays has also enabled the project team to demonstrate that the design of the antigen used in the assay can have a positive impact on its performance despite the presence of potentially interfering substances in the sera used for testing.

Paul Nitz, Panbio Chief Executive Officer said, "We are pleased with the progress the project team has made. While a number of technical challenges remain, these results increase our confidence of reaching our next goal which is to produce a prototype assay for pre-clinical evaluation by the end of 2006."

Panbio will be presenting a poster at the American Association of Clinical Chemistry (AACC) meeting in Chicago on July 27 outlining the development of the Homogeneous Assay technology to date. The AACC meeting is one of the premier meetings in the world for the medical diagnostics industry. The company will be discussing the progress of the project with a number of potential licensees of the technology.


'"/>

Contact: Dr. Stuart Hazell
61-41-305-1601
Research Australia
21-Jul-2006


Page: 1

Related biology news :

1. Breast cancer milieu -- Progression, tamoxifen sensitivity, and DNA reversion
2. Progress toward a targeted therapy for a specific form of leukemia
3. Progress against sarcoma
4. Progress toward artificial photosynthesis?
5. 2nd annual Albert Szent-Gyrgyi Prize for Progress in Cancer Research awarded to Webster K. Cavenee
6. Progress in battle against life-threatening acute allergy
7. Progress being made in exploring potential use of stem cells to treat heart disease
8. Media Invite: Dinner to award prize for Progress in Cancer Research
9. Progress needed on global regime for access to genetic resources and benefit-sharing
10. Albert Szent-Gyrgyi Prize for Progress in Cancer Research announced
11. Progress toward a new remedy for chronic urinary tract infections?

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/12/2019)... ... ... Neal O’Farrell is one of the first generation of security and privacy ... the consumer advocacy non-profit the Identity Theft Council as well as Schooled in Security, ... Commission’s Cybersecurity Roundtable and is currently a fellow of the EP3 foundation. , “I ...
(Date:4/12/2019)... ... April 12, 2019 , ... Gnubiotics ... complex microbiota accessible carbohydrates (MACs) as specialty ingredients for the global animal and ... Register and commercial launch of its first-in class microbiome modulating prebiotic GNU100, for ...
(Date:4/9/2019)... ... ... The McLeod Center for Cancer Treatment and Research has been named ... by an independent, third-party panel of experts in radiation oncology, patient safety and treatment ... is the only such cancer center in South Carolina. The hospital also represents one ...
Breaking Biology News(10 mins):
(Date:4/4/2019)... , ... April 03, 2019 , ... ... through intimate off-the-record collaboration and dialogue, today announces its Boston CEO conference to ... insights into the industry’s challenges and opportunities with high-level panels and discussions from ...
(Date:3/23/2019)... ... March 22, 2019 , ... uBiome has awarded microbiome research ... researchers at Nnamdi Azikiwe University in Anambra State, Nigeria led by Dr. Kingsley ... Department of Medical Laboratory Sciences and Deputy Provost, College of Health Sciences. The ...
(Date:3/19/2019)... Calif. (PRWEB) , ... March 19, 2019 , ... ... Konica Minolta, Inc. (Konica Minolta) today announced the formation of their inaugural Scientific ... the advancement of precision medicine that takes into account individual variability in genes, ...
(Date:3/15/2019)... PAULO and ATLANTA (PRWEB) , ... ... ... completed the acquisition of 100% equity in American Process Inc. and affiliate ... include the Alpena Biorefinery in Alpena Michigan, the Thomaston Biorefinery and R&D ...
Breaking Biology Technology:
Cached News: